Loading company details...
Beta
Latest Form 4 (Sep 24, 2026): Akos Czibere (Chief Medical Officer): Exercise/Conversion of 12,500 shares, $61.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 24, 2026 | Akos Czibere, Chief Medical Officer | Exercise/Conversion | 12,500 | $61.9K |
| Jul 22, 2026 | Ken Herrmann | Exercise/Conversion | 3,506 | $280.48 |
| Jul 20, 2026 | Ken Herrmann | Exercise/Conversion | 3,065 | $245.20 |
| Jul 10, 2026 | Shulamit Ron-Bigger, Chief Operating Officer | Exercise/Conversion | 50,000 | $183.0K |
| Jul 10, 2026 | Akos Czibere, Chief Medical Officer | Exercise/Conversion | 50,000 | $247.5K |
| Apr 16, 2026 | Glenn Gormley | Grant/Award | 37,866 | n/a |
| Jan 14, 2026 | Todd Foley | Conversion | 597,391 | n/a |
| Jan 14, 2026 | MPM BIOVENTURES 2018, L.P. | Conversion | 1,314,262 | n/a |
| Jan 14, 2026 | Ansbert Gadicke | Conversion | 1,314,262 | n/a |
| Jan 13, 2026 | EcoR1 Capital, LLC | Conversion | 2,270,879 | n/a |